Exploitation Committee
The Exploitation Committee (EC) ensures efficient exploitation of project’s results. In addition it is responsible for creating and implementing the Intellectual Property Rights (IPR) strategy by evaluation of opportunities for innovation and exploitation and is responsible for ensuring that the results of the project are exploited in the most efficient manner;
The Exploitation Committee consists of three members from the industry (Chair, equipment and biotechnology), the project coordinator and the WP leader for dissemination and exploitation (WP9). These members are:
 |
Marieke Reuver (WP9, Chair) Marieke Reuver has a background in Animal Science (MSc) from Wageningen University (the Netherlands). Currently, Marieke is AquaTT’s RTD Programme Manager. She has extensive experience in managing EC research projects, dealing specifically with knowledge management and transfer, communication and dissemination, as well as stakeholder engagement. She has been managing Aqua-tnet, the largest European network in aquaculture, fisheries and aquatic resource management involving universities, research institutes and industry, for over six years. |
 |
Dr. Fernando de la Calle Dr. Fernando de la Calle holds an Executive MBA (2005) and Ph.D in Molecular Microbiology from the Universidad Autónoma de Madrid (1998). He joined PharmaMar, Spanish company involved in advancing cancer care through the discovery and development of marine derived drugs, in 1988. Since 1999, he has had been Head of the Marine Microbiology R&D Department. The activities of his research group are focused on the study of the marine microorganisms as potential producers of antitumor compounds (drug discovery) and the design of biotechnological processes to supply drug substances. Fernando has been one of the authors of the current manufacturing process of Yondelis, a marine derived compound recently approved by the EMEA (European Union) for the treatment of soft- tissue sarcomas (2007) and recurrent ovarian cancer in combination with Caelyx® (2009). |
 |
Dr Colin Ingham (Equipment) Dr Colin Ingham trained as an academic microbiologist (PhD University College London, UK) and has a 25-year career that crosses the boundaries between academic and commercial science. Within the last 7 years work has undertaken with academic and commercial partners on micro-engineering porous aluminum oxide that culminated in the founding of Microdish BV in April 2008, with the role of CSO. |
 |
François Godart (Biotechnology) François Godart joined the Fermentalg company in 2011. He took the responsibility of the Cellular Biology Department in January 2013. He works in the field of microalgae for 6 years, including the optimization of mixotrophic and heterotrophic culture, cryopreservation or transgenesis. His professional experience was mainly gained in start-up companies. His career has brought him wide skills in cellular biology, molecular biology and biochemistry. |
 |
Prof. Dr. Lucas J. Stal (WP1, Coordinator) Royal Netherlands Institute for Sea Research (NIOZ) Prof. Dr. Lucas Stal obtained his PhD in microbial ecology from the University of Groningen (Netherlands). He worked for 10 years at the University of Oldenburg (Germany) and 8 years at the University of Amsterdam (Netherlands) before becoming head of the department of Marine Microbiology of the Netherlands Institute of Ecology in Yerseke (now NIOZ). He is also professor in Marine Microbiology at the University of Amsterdam and is an advisor of the biotech company Algenol in Berlin. He is specialized in the ecology and diversity of cyanobacteria, other marine bacteria and microalgae, and known for his work on microbial mats and nitrogen fixation |
